S. 1137, The Medical Innovation Prize Fund Act (3 comments ↓)

  • This item is from the 112th Congress (2011-2012) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
  • This bill, or a similar bill, was reintroduced in the current Congress as S. 627, The Medical Innovation Prize Fund Act.

S. 1137 would provide incentives for investment in research and development for new medicines, and it would enhance access to new medicines.

(

Learn More

    Costs: $4,809.84 per
    and increases their $162,301.27 share of the national debt by $4,809.84.
    (source info)

  • Read the Bill
  • See What People Are Saying

To What Comittee was this Bill Referred?

Visitor Comments Comments Feed for This Bill

Art Chandler

August 30, 2011, 12:58pm (report abuse)

This is another government intrusion into the private sector and our free enterprise and it will be another unwelome addition to our deficit.

Polly L Rickert

August 30, 2011, 3:07pm (report abuse)

This is ridiculous! Circumvent a process that has worked across all industries, and put the federal government right in the middle of it - yes, we really need more of THAT...What about streamlining the drug approval process and outsource the steps in the process to independent commercial labs? Maybe he should think about reducing the COST of getting drugs to market, instead of worrying about the patent on it.

Persopn of Interest

August 31, 2011, 6:27am (report abuse)

Wow. This bill is right out of "Atlas Shrugged".

RSS Feeds for This Bill

Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)